Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 811 in Subjects With Psoriasis
Clinical trial NCT01510951 · COMPLETED
Trial details
- NCT number
- NCT01510951
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2012-10-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.